Cancer Research Institute (CRI) shared on LinkedIn:
“”I was one of the first lung cancer patients to participate in a clinical trial with immunotherapy. Immediately, when I had my first infusion, I felt a difference,” says CRI ImmunoAdvocate Barry. “Something positive was going to happen.”
Discover Barry’s immunotherapy journey, during the Cancer Research Institute’s virtual Patient Immunotherapy Summit.”
Read further.
Source: Cancer Research Institute (CRI)/LinkedIn